Premium
Evaluating and Treating Cardiometabolic Risk Factors: A Case Discussion
Author(s) -
Haines Stuart T.,
Fuke Dawn C.,
Lender Dan,
Rodgers Philip T.,
Sysko Suzanne K.
Publication year - 2006
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.26.5part2.32s
Subject(s) - medicine , coronary heart disease , modalities , intensive care medicine , risk assessment , therapeutic modalities , risk analysis (engineering) , disease , computer science , social science , computer security , sociology
Reducing the risk for coronary heart disease (CHD) requires a comprehensive assessment of cardiometabolic risk factors along with the initiation of nonpharmacologic and pharmacologic therapies to mitigate these risk factors. A case study is presented to illustrate the approach to evaluating a patient and selecting among available and emerging therapeutic modalities to reduce CHD risk.